Promising Multiple Sclerosis Treatment
BOS2331 writes: "BioMS Medical Corp. (MS.TO) is a Canadian company undergoing Phase 3 trials in Canada and Europe for its patented peptide treatment for multiple sclerosis, and its U.S. Phase 3 trials are just underway. To date, the trial has successfully passed six safety reviews and the drug has shown effectiveness in slowing the progression of secondary progressive multiple sclerosis (SPMS) with no relevant side effects. Interim data is expected in mid-2008.
"I believe it is the best and most effective MS treatment at this stage, and the pharmas are beginning to line up. The management team is a formidable group that is committed to bringing this drug to people."
"Dying Is Not Much Of A Living"
Josey Wales